#Blockchain-Based DSCSA Software

[pharmaconferenceandexpo]

Regulatory Challenges in the Digital Age: Key Discussions from the 2025 Pharma Congress

Regulatory Challenges in the Digital Age: Key Discussions from the 2025 Pharma Congress Introduction

The pharmaceutical industry is undergoing a transformative shift driven by digital innovations, AI-powered drug discovery, and blockchain-based supply chain management. However, these advancements bring regulatory challenges that require a dynamic and forward-thinking approach. The 15th Digital Pharmaceutical Innovations Exhibition & Congress (May 14–16, 2025) will serve as a critical platform to discuss these evolving challenges.

Regulatory bodies worldwide are working to keep pace with new technologies, balancing patient safety with innovation. As part of the Silver Sponsorship at this prestigious event, we will explore the most pressing regulatory hurdles and share expert insights on how the industry can adapt to this rapidly changing environment.

Key Keywords:

Digital Transformation in Pharma

Regulatory Challenges in Drug Discovery

AI and Compliance in Pharmaceuticals

Blockchain in Pharma Supply Chains

FDA & EMA Digital Regulations

Data Privacy and Cybersecurity in Pharma

Future of Digital Pharma Compliance

Global Regulatory Harmonization

Digital Health Regulation

Ethical AI in Pharma

Key Discussions from the 2025 Pharma Congress

1. AI and Machine Learning in Drug Development: Regulatory Dilemmas

Artificial Intelligence is revolutionizing pharmaceutical R&D, but it also raises concerns about data integrity, algorithmic transparency, and regulatory oversight. Regulators like the FDA and EMA are working on guidelines for AI validation and compliance, but there’s still a long way to go.

One of the key discussions at the congress will be the need for explainability in AI-driven drug development. Regulators are pushing for "glass-box" AI models over "black-box" systems to ensure transparency and accountability in clinical decisions. Companies leveraging AI will need to integrate robust validation and monitoring mechanisms to comply with evolving regulations.

2. Blockchain and Supply Chain Transparency: Compliance Hurdles

Blockchain technology promises tamper-proof, transparent tracking of drugs from manufacturing to end users. However, global regulatory frameworks are still catching up with the legal and technical implications of decentralized ledgers in the pharmaceutical supply chain.

For example, the U.S. Drug Supply Chain Security Act (DSCSA) mandates serialized tracking of prescription drugs. Blockchain can support compliance, but regulatory agencies require interoperability and governance standards. The congress will explore best practices for integrating blockchain with existing regulatory frameworks.

3. Digital Therapeutics and Personalized Medicine: Approval Pathways

As digital therapeutics and AI-driven personalized medicine gain traction, regulatory agencies must refine approval processes. The challenge is determining how traditional drug approval frameworks can adapt to software-based treatments and AI-driven diagnostics.

A key concern is the Software as a Medical Device (SaMD) classification. Regulators must define risk-based categories for digital therapeutics, ensuring they meet safety and efficacy standards without stifling innovation. The congress will host discussions on accelerating regulatory approvals while maintaining patient safety.

4. Data Privacy, Cybersecurity, and Compliance Risks

With the rise of digital health records and cloud-based drug development platforms, data security is a major concern. The pharma industry must navigate stringent regulations such as GDPR, HIPAA, and the evolving AI Act to ensure compliance without hindering innovation.

Cybersecurity threats, including ransomware attacks and data breaches, pose significant risks to pharmaceutical companies handling patient data. Regulatory agencies are introducing stricter penalties for non-compliance, making it crucial for companies to implement robust cybersecurity frameworks. Experts at the congress will discuss proactive strategies to mitigate digital security threats.

5. Real-World Evidence (RWE) and Regulatory Acceptance

Regulatory agencies are increasingly looking at real-world evidence (RWE) to support drug approvals, but there are gaps in standardization and validation. The congress will explore how regulatory bodies are shaping policies to integrate RWE into decision-making.

One of the key challenges is ensuring data integrity and minimizing bias in real-world data collection. The congress will feature case studies on successful RWE adoption and discuss strategies for standardizing methodologies across global markets.

6. Global Regulatory Harmonization: Bridging the Gaps

Pharmaceutical companies operating in multiple markets face challenges in complying with diverse regulatory requirements. The lack of harmonized guidelines can slow down drug approvals and increase operational complexity.

The International Council for Harmonization (ICH) is working on global regulatory alignment, but there are still inconsistencies in areas like AI governance, digital therapeutics approval, and data privacy. The congress will highlight efforts to streamline regulatory compliance across regions and foster greater collaboration between agencies.

Q&A: Addressing the Benefits and Challenges

Q1: How do regulatory bodies approach AI in drug development? A1: The FDA and EMA are actively working on guidelines to standardize AI validation, focusing on transparency, bias mitigation, and data security. Companies must ensure their AI models comply with evolving regulatory frameworks.

Q2: What are the major compliance risks associated with blockchain in pharma? A2: While blockchain enhances transparency, it poses challenges in regulatory recognition, cross-border compliance, and data governance. Companies must align with regulatory guidelines to avoid legal complications.

Q3: How does data privacy regulation impact pharmaceutical digitalization? A3: Regulations such as GDPR and HIPAA impose strict data protection rules. Pharma companies need robust cybersecurity strategies to safeguard patient data and ensure regulatory compliance.

Q4: Why is real-world evidence (RWE) becoming crucial in regulatory approvals? A4: RWE provides valuable insights into a drug’s real-world performance, improving regulatory decision-making. However, standardizing RWE collection and analysis remains a challenge.

Q5: How can global regulatory harmonization benefit the pharma industry? A5: A unified regulatory framework can reduce approval timelines, cut compliance costs, and facilitate faster market entry for innovative drugs. The congress will address collaborative initiatives toward harmonization.

Conclusion

The digital age presents both opportunities and regulatory challenges for the pharmaceutical industry. As companies embrace AI, blockchain, and digital therapeutics, compliance strategies must evolve in parallel. The 15th Digital Pharmaceutical Innovations Exhibition & Congress is the perfect forum to discuss these critical issues and shape the future of digital pharma regulations.

Join the conversation and register today: https://pharmacy.utilitarianconferences.com/registration

Hashtags:

#DigitalPharma #PharmaRegulations #AIinPharma #BlockchainPharma #PharmaCompliance #DrugDiscovery #DigitalTransformation #PharmaTech #PharmaCongress2025 #RegulatoryHarmonization #RealWorldEvidence #SaMD #CybersecurityInPharma

👉 Register here: https://pharmacy.utilitarianconferences.com/registration

Website: https://utilitarianconferences.com/

Twitter: @UCGConferences LinkedIn :https://www.linkedin.com/feed/

To know more abouts topics:- https://youtu.be/qHB0286VJSI?si=rGRqgamVnV7ZNkyT

[health-views-updates]

Investing in the Track and Trace Solutions Market: Key Considerations and Opportunities

The global track and trace solutions market revenue is set for significant growth, with a projected compound annual growth rate (CAGR) of 19.1% from 2023 to 2030. Valued at USD 3.51 billion in 2022, the market is expected to reach USD 14.21 billion by 2030. The increasing need for effective tracking systems across various industries is driving this robust expansion.

Track and trace solutions are designed to monitor the movement of products throughout the supply chain, from manufacturing to the end consumer. These systems enable businesses to track goods in real time, ensuring transparency, reducing counterfeit risks, and maintaining compliance with regulatory requirements. The solutions play a vital role in sectors such as pharmaceuticals, food & beverages, consumer goods, and logistics.

Key Factors Driving Market Growth

The surge in demand for track and trace solutions is primarily fueled by the increasing need for transparency and accountability across supply chains. In the pharmaceutical industry, for instance, stringent regulations around the world mandate the use of track and trace systems to prevent counterfeit drugs from entering the market. Governments and regulatory bodies are enforcing strict compliance standards to ensure product safety, which has led to widespread adoption of these solutions by manufacturers and distributors.

Moreover, the growing global trade of consumer goods has also emphasized the need for sophisticated track and trace technologies. Companies across the world are investing in systems that help them maintain end-to-end visibility of their supply chains, ensuring that products are delivered safely and efficiently. Technologies such as RFID, barcode scanners, and cloud-based tracking software are increasingly being integrated to provide seamless tracking and monitoring of goods.

 Get Free Sample Report: https://www.snsinsider.com/sample-request/1902 

Technological Advancements and Integration

The track and trace solutions market is experiencing rapid technological advancements, particularly with the integration of artificial intelligence (AI) and the Internet of Things (IoT). AI-powered analytics can help companies predict potential disruptions in the supply chain, enabling them to make proactive decisions. Meanwhile, IoT devices facilitate real-time tracking, offering precise information on the location and condition of products during transit.

Blockchain technology is also gaining traction in this market, as it offers secure, tamper-proof tracking systems that ensure data integrity and transparency. Companies are increasingly adopting blockchain-based solutions to enhance trust and improve collaboration across the supply chain.

Regional Market Insights

North America currently dominates the track and trace solutions market, driven by stringent regulatory frameworks and the high adoption rate of advanced technologies. The United States, in particular, has seen significant investments in the implementation of track and trace systems in the pharmaceutical sector to comply with the Drug Supply Chain Security Act (DSCSA).

Europe is also a prominent market, with strong government regulations aimed at combating counterfeit goods. However, the Asia-Pacific region is expected to witness the highest growth rate during the forecast period. Factors such as expanding pharmaceutical manufacturing, rising exports, and increased adoption of digital technologies are contributing to this growth. Countries like China, India, and Japan are investing heavily in track and trace technologies to ensure product authenticity and safety.

Future Outlook

The track and trace solutions market is poised for sustained growth, supported by rising concerns over product safety, the need for efficient supply chain management, and increasing regulatory compliance requirements. With the expansion of global trade, companies are more than ever seeking robust systems that provide visibility, traceability, and assurance of product quality throughout the supply chain.

In conclusion, the track and trace solutions market, which was valued at USD 3.51 billion in 2022, is on track to reach USD 14.21 billion by 2030, reflecting a strong CAGR of 19.1% over the forecast period. The adoption of advanced technologies, coupled with regulatory mandates and the need for effective supply chain management, will continue to drive market growth in the years to come.

Other Trending Reports

Liver Cancer Therapeutics Market Size

Biotechnology Reagents & Kits Market Size

Automated Liquid Handling Technologies Market Size

Biotechnology Market Size

[interwork2018-blog]

DRUG SUPPLY CHAIN SECURITY ACT: COMPLIANCE IS NOT AS DIFFICULT AS YOU THINK

DSCSA Compliance, Difficulties, and Solutions

Among a lot of reasons that are presently surfacing around FDA track and trace capability, most primitive ones are misconceptions around the definition of product identification and verification. The other is financial, commercial, and infrastructural gaps between large, small, and mid-size companies.

Verification? Product Identification? Definitions Under DSCSA

There are essential issues in how the modern pharmaceutical industry interprets product identification and verification. It is often misunderstood that verification of product identification means that the manufacturer, repackager, is expected to verify whether they make the product. Or there is an identification on the counterfeit in a particular Pharma supply chain automatically point in time.

As per DSCSA identification and verification definition, the manufacturers and the higher-level partners in a supply chain have been bound to ensure (at any time) that a particular request a product verification helps them verify that the product. It includes an identification number, lot number, and other details that are the same as available on the human-readable label and the one submitted to the USFDA regulators.

Resource & Commercial Gaps Among Companies

The commercial, financial, and business capabilities of a well-established pharmaceutical giant, a mid-scale company, or a freshly approved Pharma company would be different. DSCSA compliance is facing significant hurdles. The large-cap companies are capable of undertaking the serialization process and make the necessary changes in their production facilities. But, they are lacking the right business leadership and the required information for successfully carrying out the compliance process. The mid-scale and small pharmaceutical companies are having significant trouble in building a commercially feasible manufacturing and supply chain model. The focus is on embedding the serialization process via contacted manufacturers or a portion of it that remains in the house.

No Standardization of the Serialization Process

One of the hurdles faced by the DSCSA serialization process is that there is no standardization of the serialization process. New-age startups and well-established companies and their CMOS or CIOs are coming out with consultancy services ‘Serialisation as a Service’ concept consulting the short, less resourceful time to managing to get through these processes. Industry experts and thought leaders have outrightly dishonored the idea of one to one consultancy on a global matter, and it is not advisable.

Benefits of

DSCSA Compliance

and Why Every US Pharma Business Needs It?What Is The Real Solution?

DSCSA Compliance can be best managed with strategized, well-structured intervention of technology product that is capable of foolproof security, safety, and data security compromise concerns. It should be bringing all the primary and secondary stakeholders of a farmer supply chain to a single solution. Standardization of the serialization process and decentralization of information is a must. The centralization of vigilance should tope it and policing efforts. They are more critical for a sustainable, successful stride of DSCSA Compliance with the help of DSCSA Software.

What Makes DSCSA Compliance More Feasible?

There have been various entrant Technology Solutions that are getting on and off the Pharmaceutical Landscape. A completely foolproof, robust Blockchain-Based Serialization Solution, DSCSA Software is all you need. Fortunately, the Blockchain is one Technology that is capable of documenting Transactions on a Decentralized database with 99.99% data immutability at all ends. It is the perfect solution allowing a vast number of private or permissioned vendors to register over a Blockchain Platform voluntarily.

It verifies the profile and makes them a part of a wholly secured, highly transparent Pharma Supply Chain Solution. It is a great Solution that Allows Real-time Transactions and foolproof consensus management across all regulators and the leading supply chain partners. It helps in executing supplies across the pharmaceutical consumer base.

Business Benefits of using a

DSCSA Compliance Software

No FDA penalties

Keeping all Pharmaceutical Supply Chain operations abiding by the Serialization process drastically reduces the chances of ending up FDA sanctions and suspension of Services.

Complete Security

Blockchain day, The Traceability Solutions, and DSCSA Software bring SCM operations a lot closer to the SCM compliance eliminating all possibilities of stolen, counter feet, and low activity Drugs.

Secured Scalability

Expanding wide across more Rx rugs for Manufacturing deep down the consumer base is more affordable and feasible with an end to end Serialization Solution.

Business Beyond Boundaries

The power of Blockchain-Based Private and Formation Registries over the Blockchain Platform to successfully impaneled vendors and officially communicate with other partners in the Supply Chain anywhere across the world.

Bulletproof data security

Blockchain Technology is capable of building a decent life Database with imitable Data records in the form of Smart Contracts. All the product-related information and Realtime Transactions are highly secured.

Reduced Compliance Costs

DSCSA Software Solution is capable of drastically reducing the overall compliance cost, which in turn causes higher profitability in the long run.

Eight Times Better Fault Tolerance

Blockchain-Based DSCSA Software enables suppliers and partners and regulators to identify notice, red flag, quarantine that are passed into the Supply Chain just with the help of a click.

Cost-Effective SCM

The high efficient DSCSA Compliance Software enables companies to focus on cutting costs department wise.

Higher Productivity

The Highly Secured and process includes resource utilization rates and makes the human resource capital way more efficient than ever before.

Conclusion

Forceful intrusions of Technology in Pharmaceutical Traceability and Serialization can make DSCSA Compliance way more comfortable than it looks from the outside. Highly robust, new-age Blockchain-Based DSCSA Software eliminates the hassles of building and managing a Technology Platform. Now you can Setup Serialization Solutions with leading Blockchain Development Companies that are making efforts towards standardizing the process Drug Serialization on a Global Scale.

[i-globalone]

This post is part of CoinDesk’s 2019 Year in Review, a collection of 100 op-eds, interviews and takes on the state of blockchain and the world. Dr. Alex Cahana is head of healthcare and blockchain consulting at Genesis Block.At the end of 2018, while awakening from the Crypto Winter, a group of noted healthcare professionals led by Mayo Clinic’s John Halamka predicted that 2019 would be a pivotal year for blockchain in the healthcare industry. They said blockchain would become an essential part of consent management, improve remittances and enhance the monetization of personal data. It would tokenize non-cash assets, like patient outcomes, as an incentive to improve health. How much of this agenda was actually realized? The answer is some, but not all. We have seen blockchain deployments in supply chains and for physician credentialing, but not yet implemented as an architecture of electronic health records intended to transform them into self-sovereign, patient-driven digital assets. Why is that, or more fundamentally, why use blockchain in healthcare at all?Healthcare is problematic all over the world. From a patient point of view, healthcare is not always readily accessible and in many cases too expensive. From a healthcare professional’s perspective, there is too much paperwork. For hospital executives, unchecked job growth rate has not translated into better patient outcomes. The future of pharma and digital therapies is fraught with uncertainty. And even insurance brokers have experienced reduced or eliminated commissions on the sale of individual health plans. At least, we can all agree that the healthcare ecosystem is a multi-stakeholder, mal-aligned, friction-full, opaque, heavily-regulated, lacking-of-trust, data-rich environment. From there, we can agree on the need for new responses and approaches, including the use of blockchain. It turns out that blockchain-based platforms are ideal for dealing with the characteristics that plague healthcare.Robert Miller, of ConsenSys Health, produced an excellent report this summer summarizing major trends in the blockchain health space. These include the formation of major new business networks around healthcare use-cases, greater VC funding, and as already mentioned, the use of blockchain for credentialing. This year, half a dozen consortias (like IBM’s Health Utility Network [HUN], Coalesce Health Alliance and MELLODY) announced projects to exchange healthcare and life science data on  using permissioned distributed ledgers. That’s a big deal. Together, these consortia touch the lives of  millions of customers (HUN covers 80 million beneficiaries) in a multi-billion dollar market (MELLODY includes pharma companies with a collective value of more than $300 billion).Venture capital flows have actually slowed, reaching $25M in VC funding this year ($16M of them for Chronicled). This amount is still lower than the $100M-plus raised in 2018 and represents a ridiculously miniscule fraction of the $6B VC funding for non-blockchain digital health projects. As for STOs, the nearly $1B raise in 124 deals included only seven healthcare projects (like Healthbank, Healthereum, Verseon and Agenus), with no significant reported raises.Supply chain applications and physician credentialing are the most common use-cases in healthcare blockchain. The Drug Supply Chain Security Act (DSCSA) of 2013, which mandated the creation of an electronic, interoperable system that can trace and identify distributed prescription drugs, catalyzed the development of a few large scale blockchain-based platforms (like IDLogiq, MediLedger, Rymedi and TraceLink). As for physician credentialing, we’ve seen a multitude of DLT credentialing solutions emerge (like ProCredX developed by HashedHealth, Blockcerts used by the Federation of State Medical Boards, IntivaHealth that maintains records for continuing education and Truu, used by the UK National Health System). But currently these solutions (except Truu) are exclusively business-to-business and do not address the problem of physician identity or improve professional mobility. So what can we expect in 2020? As Nikhil Krishnan correctly predicted in his CB Insight report, the growing blockchain and healthcare landscape (48% CAGR till 2027) is currently dominated by closed consortia, where patient data is minimally used, under strict HIPPA or GDPR regulation. The idea that personal health information in the hands of patients are part of an immutable, master health record has been implemented in Estonia. But it looks like US adoption will be impeded due to a lack of political, regulatory and social appetite to change healthcare from a centralized, corporate, for-profit system into a self-sovereign, decentralized, doctor-patient-driven one.Whether 2020 will be an incremental or transformational year depends on three factors in my opinion.First, will we educate healthcare professionals by using a better, refined language? Already we shy away from using the words “crypto” and “blockchain,” associated with hacking and greed (thank you Mt. Gox and ICOs) and use the term DLT. But if we really want to recruit the public, we also need to talk about re-intermediation instead of disintermediation, coopetition (collaborative competition) instead of competition and distinguish between a sustainable “open” market (open to producers) vs. a non-sustainable “free” market, that includes also non- and counter-producers that manipulate and destroy the market (for details, read about Radical Markets here). In other words, the story shouldn’t be about technology, but what technology can achieve for healthcare and its stakeholders.Second, will we start to explain why we should use blockchain and stop just describing it? Yes, for blockchain to work it must be, as Toufi Saliba, CEO of the TODA Network says:  SECSI (Secure, Efficient, Confidential, Scalable, Interoperable). But doctors don’t care that blockchain is a ledger and are not interested in explanations about PoS, PoW, sharding and DAGs. Healthcare professionals need to understand that the “secret sauce” behind using Blockchain in their practice is that their relationship with patients has an inherent value. By promoting patient health, doctors actually engage in a peer-to-peer economic activity and can reward patients and be rewarded for healthy behaviour. Patient outcome is thus an invested asset (store of value) that can be traded not only by companies (Google, FitBit, 23andMe and ZocDoc) but also by patients and professionals themselves.And third, the 2020 US election outcome. As institutional trust erodes (think government, certain media outlets, Facebook), distributed trust has emerged as an attack-, collusion- and censorship- resistant model to procure, curate, store, manage and analyze data and information. But the public doesn’t understand the difference between universal access to healthcare, which is enhanced when using a distributed, decentralized economic model, and Medicare-for-All (or Amazon-for-All) which is a centralized, friction-full monopsonistic system. Resolving this confusion will be important for blockchain’s future prospects in the healthcare space. As healthcare remains the top issue on voters’ minds this year, the country remains evenly split on whether we should have a very centralized system (Medicare-for-all), a somewhat centralized one (ACA or “Obamacare) or state-based “distributed” (but not decentralized) healthcare. I doubt DLT will be horizontally integrated this year or leveraged as a tool to transform healthcare’s business model and looking ahead to 2020, that future seems some way off given the largely centralized, corporate, for-profit healthcare system in the United States. Nonetheless healthcare provides a very strong, if not perfect use-case for blockchain software solutions. It uses a shared repository (EHRs) with multiple writers (doctors, nurses, staff) and it has transaction dependencies (adherence to treatment plans, payments, regulations) with multiple intermediaries (professionals, patients, payors, regulators) that have no or minimal trust between them. Blockchain is poised to remedy many of these shortcomings.Finally, instead of pointing out what blockchain is missing, or fret that its purpose is unclear and changing, or hedge on what blockchain will become, let us state clearly what blockchain does. It is an attack, collusion and censorship-resistant solution that facilitates peer-to-peer economic activity. And in a world that suffers from a fear of fake products (fake posts, fake news and fake data), the role of DLT as solving the problem of social “fakes” is salient.Disclosure Read More The leader in blockchain news, CoinDesk is a media outlet that strives for the highest journalistic standards and abides by a strict set of editorial policies. CoinDesk is an independent operating subsidiary of Digital Currency Group, which invests in cryptocurrencies and blockchain startups.

http://www.globalone.com.np/2019/12/is-blockchain-shot-in-arm-healthcare.html

[vanessawestwcrtr5]

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Blockchain technology can improve how researchers access medical data.Pixabay.

This distributed ledger technology can improve security, efficiency, and the coordination of health care systems as an answer to aging legacy infrastructures.

Health care systems are cornerstones of all modern societies since they provide vital services. As they grow, however, many become less efficient and secure, which can make health care services more expensive and less accessible to the general public. Beyond being the buzzword of 2017, blockchain opens the door to solutions in an increasing global healthcare expenditure that is expected to increase to USD $10.059 trillion by 2022.

Healthcare Today

While the digitization of healthcare has paved the way for modern infrastructure, current privacy laws, software, and databases have slowly taken the power from the patient. Our existing software faces a few key problems that have both short-term and long-term implications—affecting both healthcare providers and their patients. Inefficiency, disjunction between databases, the disempowerment of patients, high expenses, and security concerns are just some of the many problems the healthcare industry faces.

With a move towards ease of access to data and decentralization in a world where security continues to pose a serious risk, blockchain is becoming the answer to many industry-wide obstacles. Here is how blockchain is applied to many of industry’s burgeoning issues:

Security

Healthcare systems are being targeted by cyber attacks because their legacy infrastructures make data vulnerable. In 2017, the ransomware “WannaCry” crippled the National Health Service (NHS) in the United Kingdom and affected over 150 countries. In 2018 and 2019 respectively, hackers broke into Singapore’s government health database and most recently the HIV status of over 14,000 people leaked online, Singapore authorities say.

Given that blockchain is a distributed ledger technology and does not require third-party interventions, it allows institutions to decentralize their databases. Hence, by using blockchain, health care systems can significantly reduce their risk of being subject to cyber threats. It would take too much time and energy for hackers to access all of the nodes within the network and to infect the system.

It is highly important to create an environment where clinicians, administrators, and patients (also known as consumers of healthcare) know that their privacy and data are protected. Such an ecosystem can be enabled by blockchain, either by allowing users to own their information by joining the chain or by helping hospitals to secure their servers and distribute the data on a network.

Physicians and administrators can significantly benefit from blockchain as the technology would allow them to share a common platform.Pixabay

Efficiency & Coordination

Health care systems are remarkably inefficient. Since they operate with many independent databases, especially in large centralized systems, there is a lack of cohesive communication between these distinct silos. By creating a unified ecosystem of data, distributed ledger software encourages cooperation between networks, improving payment processing, patient tracking, and enterprise workflow.

Sectors like the food industry are already seeing wins with blockchain that healthcare can emulate in regards to supply chain management.  Companies like Walmart implemented IBM’s blockchain for food traceability, impacting pharmaceutical stakeholders to participate in the non-profit Center For Supply Chain Studies DSCSA and Blockchain Phase 2 Study. The FDA who is behind this initiative, as declared by current FDA Commissioner Gottleib requires all entities governed under FDA  “full implementation of the Drug Supply Chain Security Act, [and] to make sure that every link in the U.S. Drug Supply must be secure.”

Other emerging use cases such as clinical trials involve the management of numerous locations, sources, and stakeholders, along with supervision of substantial amounts of sensitive data. Since blockchain may facilitate data storage, the technology can fuel innovation, as researchers will have greater access to medical record information.

The Future of Healthcare

Blockchain technology is expected to transform the way key players in health care systems interact with each other. Nonetheless, this technological revolution can only succeed with consortium thinking, which implies collaboration between all stakeholders in the sector. In the United States, Synaptic Health Alliance, a diverse consortium of healthcare organizations and other emerging startup consortia are working to identify and monetize shared opportunities in the blockchain space.

Blockchain is not without its problems.

Right now the initial costs can be high, and the integrations need to happen. Currently, most blockchain networks are designed so transactions are publicly accessible. While blockchain systems can be made private and permissible, making it so only certain parties can access boils down to aligned incentives. But it’s clear that the technology is there and can change healthcare for good.

Source link http://bit.ly/2GvON7c

[adrianjenkins952wblr]

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Blockchain technology can improve how researchers access medical data.Pixabay.

This distributed ledger technology can improve security, efficiency, and the coordination of health care systems as an answer to aging legacy infrastructures.

Health care systems are cornerstones of all modern societies since they provide vital services. As they grow, however, many become less efficient and secure, which can make health care services more expensive and less accessible to the general public. Beyond being the buzzword of 2017, blockchain opens the door to solutions in an increasing global healthcare expenditure that is expected to increase to USD $10.059 trillion by 2022.

Healthcare Today

While the digitization of healthcare has paved the way for modern infrastructure, current privacy laws, software, and databases have slowly taken the power from the patient. Our existing software faces a few key problems that have both short-term and long-term implications—affecting both healthcare providers and their patients. Inefficiency, disjunction between databases, the disempowerment of patients, high expenses, and security concerns are just some of the many problems the healthcare industry faces.

With a move towards ease of access to data and decentralization in a world where security continues to pose a serious risk, blockchain is becoming the answer to many industry-wide obstacles. Here is how blockchain is applied to many of industry’s burgeoning issues:

Security

Healthcare systems are being targeted by cyber attacks because their legacy infrastructures make data vulnerable. In 2017, the ransomware “WannaCry” crippled the National Health Service (NHS) in the United Kingdom and affected over 150 countries. In 2018 and 2019 respectively, hackers broke into Singapore’s government health database and most recently the HIV status of over 14,000 people leaked online, Singapore authorities say.

Given that blockchain is a distributed ledger technology and does not require third-party interventions, it allows institutions to decentralize their databases. Hence, by using blockchain, health care systems can significantly reduce their risk of being subject to cyber threats. It would take too much time and energy for hackers to access all of the nodes within the network and to infect the system.

It is highly important to create an environment where clinicians, administrators, and patients (also known as consumers of healthcare) know that their privacy and data are protected. Such an ecosystem can be enabled by blockchain, either by allowing users to own their information by joining the chain or by helping hospitals to secure their servers and distribute the data on a network.

Physicians and administrators can significantly benefit from blockchain as the technology would allow them to share a common platform.Pixabay

Efficiency & Coordination

Health care systems are remarkably inefficient. Since they operate with many independent databases, especially in large centralized systems, there is a lack of cohesive communication between these distinct silos. By creating a unified ecosystem of data, distributed ledger software encourages cooperation between networks, improving payment processing, patient tracking, and enterprise workflow.

Sectors like the food industry are already seeing wins with blockchain that healthcare can emulate in regards to supply chain management.  Companies like Walmart implemented IBM’s blockchain for food traceability, impacting pharmaceutical stakeholders to participate in the non-profit Center For Supply Chain Studies DSCSA and Blockchain Phase 2 Study. The FDA who is behind this initiative, as declared by current FDA Commissioner Gottleib requires all entities governed under FDA  “full implementation of the Drug Supply Chain Security Act, [and] to make sure that every link in the U.S. Drug Supply must be secure.”

Other emerging use cases such as clinical trials involve the management of numerous locations, sources, and stakeholders, along with supervision of substantial amounts of sensitive data. Since blockchain may facilitate data storage, the technology can fuel innovation, as researchers will have greater access to medical record information.

The Future of Healthcare

Blockchain technology is expected to transform the way key players in health care systems interact with each other. Nonetheless, this technological revolution can only succeed with consortium thinking, which implies collaboration between all stakeholders in the sector. In the United States, Synaptic Health Alliance, a diverse consortium of healthcare organizations and other emerging startup consortia are working to identify and monetize shared opportunities in the blockchain space.

Blockchain is not without its problems.

Right now the initial costs can be high, and the integrations need to happen. Currently, most blockchain networks are designed so transactions are publicly accessible. While blockchain systems can be made private and permissible, making it so only certain parties can access boils down to aligned incentives. But it’s clear that the technology is there and can change healthcare for good.

Source link http://bit.ly/2GvON7c

[courtneyvbrooks87]

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Blockchain technology can improve how researchers access medical data.Pixabay.

This distributed ledger technology can improve security, efficiency, and the coordination of health care systems as an answer to aging legacy infrastructures.

Health care systems are cornerstones of all modern societies since they provide vital services. As they grow, however, many become less efficient and secure, which can make health care services more expensive and less accessible to the general public. Beyond being the buzzword of 2017, blockchain opens the door to solutions in an increasing global healthcare expenditure that is expected to increase to USD $10.059 trillion by 2022.

Healthcare Today

While the digitization of healthcare has paved the way for modern infrastructure, current privacy laws, software, and databases have slowly taken the power from the patient. Our existing software faces a few key problems that have both short-term and long-term implications—affecting both healthcare providers and their patients. Inefficiency, disjunction between databases, the disempowerment of patients, high expenses, and security concerns are just some of the many problems the healthcare industry faces.

With a move towards ease of access to data and decentralization in a world where security continues to pose a serious risk, blockchain is becoming the answer to many industry-wide obstacles. Here is how blockchain is applied to many of industry’s burgeoning issues:

Security

Healthcare systems are being targeted by cyber attacks because their legacy infrastructures make data vulnerable. In 2017, the ransomware “WannaCry” crippled the National Health Service (NHS) in the United Kingdom and affected over 150 countries. In 2018 and 2019 respectively, hackers broke into Singapore’s government health database and most recently the HIV status of over 14,000 people leaked online, Singapore authorities say.

Given that blockchain is a distributed ledger technology and does not require third-party interventions, it allows institutions to decentralize their databases. Hence, by using blockchain, health care systems can significantly reduce their risk of being subject to cyber threats. It would take too much time and energy for hackers to access all of the nodes within the network and to infect the system.

It is highly important to create an environment where clinicians, administrators, and patients (also known as consumers of healthcare) know that their privacy and data are protected. Such an ecosystem can be enabled by blockchain, either by allowing users to own their information by joining the chain or by helping hospitals to secure their servers and distribute the data on a network.

Physicians and administrators can significantly benefit from blockchain as the technology would allow them to share a common platform.Pixabay

Efficiency & Coordination

Health care systems are remarkably inefficient. Since they operate with many independent databases, especially in large centralized systems, there is a lack of cohesive communication between these distinct silos. By creating a unified ecosystem of data, distributed ledger software encourages cooperation between networks, improving payment processing, patient tracking, and enterprise workflow.

Sectors like the food industry are already seeing wins with blockchain that healthcare can emulate in regards to supply chain management.  Companies like Walmart implemented IBM’s blockchain for food traceability, impacting pharmaceutical stakeholders to participate in the non-profit Center For Supply Chain Studies DSCSA and Blockchain Phase 2 Study. The FDA who is behind this initiative, as declared by current FDA Commissioner Gottleib requires all entities governed under FDA  “full implementation of the Drug Supply Chain Security Act, [and] to make sure that every link in the U.S. Drug Supply must be secure.”

Other emerging use cases such as clinical trials involve the management of numerous locations, sources, and stakeholders, along with supervision of substantial amounts of sensitive data. Since blockchain may facilitate data storage, the technology can fuel innovation, as researchers will have greater access to medical record information.

The Future of Healthcare

Blockchain technology is expected to transform the way key players in health care systems interact with each other. Nonetheless, this technological revolution can only succeed with consortium thinking, which implies collaboration between all stakeholders in the sector. In the United States, Synaptic Health Alliance, a diverse consortium of healthcare organizations and other emerging startup consortia are working to identify and monetize shared opportunities in the blockchain space.

Blockchain is not without its problems.

Right now the initial costs can be high, and the integrations need to happen. Currently, most blockchain networks are designed so transactions are publicly accessible. While blockchain systems can be made private and permissible, making it so only certain parties can access boils down to aligned incentives. But it’s clear that the technology is there and can change healthcare for good.

Source link http://bit.ly/2GvON7c

[teiraymondmccoy78]

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Blockchain technology can improve how researchers access medical data.Pixabay.

This distributed ledger technology can improve security, efficiency, and the coordination of health care systems as an answer to aging legacy infrastructures.

Health care systems are cornerstones of all modern societies since they provide vital services. As they grow, however, many become less efficient and secure, which can make health care services more expensive and less accessible to the general public. Beyond being the buzzword of 2017, blockchain opens the door to solutions in an increasing global healthcare expenditure that is expected to increase to USD $10.059 trillion by 2022.

Healthcare Today

While the digitization of healthcare has paved the way for modern infrastructure, current privacy laws, software, and databases have slowly taken the power from the patient. Our existing software faces a few key problems that have both short-term and long-term implications—affecting both healthcare providers and their patients. Inefficiency, disjunction between databases, the disempowerment of patients, high expenses, and security concerns are just some of the many problems the healthcare industry faces.

With a move towards ease of access to data and decentralization in a world where security continues to pose a serious risk, blockchain is becoming the answer to many industry-wide obstacles. Here is how blockchain is applied to many of industry’s burgeoning issues:

Security

Healthcare systems are being targeted by cyber attacks because their legacy infrastructures make data vulnerable. In 2017, the ransomware “WannaCry” crippled the National Health Service (NHS) in the United Kingdom and affected over 150 countries. In 2018 and 2019 respectively, hackers broke into Singapore’s government health database and most recently the HIV status of over 14,000 people leaked online, Singapore authorities say.

Given that blockchain is a distributed ledger technology and does not require third-party interventions, it allows institutions to decentralize their databases. Hence, by using blockchain, health care systems can significantly reduce their risk of being subject to cyber threats. It would take too much time and energy for hackers to access all of the nodes within the network and to infect the system.

It is highly important to create an environment where clinicians, administrators, and patients (also known as consumers of healthcare) know that their privacy and data are protected. Such an ecosystem can be enabled by blockchain, either by allowing users to own their information by joining the chain or by helping hospitals to secure their servers and distribute the data on a network.

Physicians and administrators can significantly benefit from blockchain as the technology would allow them to share a common platform.Pixabay

Efficiency & Coordination

Health care systems are remarkably inefficient. Since they operate with many independent databases, especially in large centralized systems, there is a lack of cohesive communication between these distinct silos. By creating a unified ecosystem of data, distributed ledger software encourages cooperation between networks, improving payment processing, patient tracking, and enterprise workflow.

Sectors like the food industry are already seeing wins with blockchain that healthcare can emulate in regards to supply chain management.  Companies like Walmart implemented IBM’s blockchain for food traceability, impacting pharmaceutical stakeholders to participate in the non-profit Center For Supply Chain Studies DSCSA and Blockchain Phase 2 Study. The FDA who is behind this initiative, as declared by current FDA Commissioner Gottleib requires all entities governed under FDA  “full implementation of the Drug Supply Chain Security Act, [and] to make sure that every link in the U.S. Drug Supply must be secure.”

Other emerging use cases such as clinical trials involve the management of numerous locations, sources, and stakeholders, along with supervision of substantial amounts of sensitive data. Since blockchain may facilitate data storage, the technology can fuel innovation, as researchers will have greater access to medical record information.

The Future of Healthcare

Blockchain technology is expected to transform the way key players in health care systems interact with each other. Nonetheless, this technological revolution can only succeed with consortium thinking, which implies collaboration between all stakeholders in the sector. In the United States, Synaptic Health Alliance, a diverse consortium of healthcare organizations and other emerging startup consortia are working to identify and monetize shared opportunities in the blockchain space.

Blockchain is not without its problems.

Right now the initial costs can be high, and the integrations need to happen. Currently, most blockchain networks are designed so transactions are publicly accessible. While blockchain systems can be made private and permissible, making it so only certain parties can access boils down to aligned incentives. But it’s clear that the technology is there and can change healthcare for good.

Source link http://bit.ly/2GvON7c

[bobbynolanios88]

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Blockchain technology can improve how researchers access medical data.Pixabay.

This distributed ledger technology can improve security, efficiency, and the coordination of health care systems as an answer to aging legacy infrastructures.

Health care systems are cornerstones of all modern societies since they provide vital services. As they grow, however, many become less efficient and secure, which can make health care services more expensive and less accessible to the general public. Beyond being the buzzword of 2017, blockchain opens the door to solutions in an increasing global healthcare expenditure that is expected to increase to USD $10.059 trillion by 2022.

Healthcare Today

While the digitization of healthcare has paved the way for modern infrastructure, current privacy laws, software, and databases have slowly taken the power from the patient. Our existing software faces a few key problems that have both short-term and long-term implications—affecting both healthcare providers and their patients. Inefficiency, disjunction between databases, the disempowerment of patients, high expenses, and security concerns are just some of the many problems the healthcare industry faces.

With a move towards ease of access to data and decentralization in a world where security continues to pose a serious risk, blockchain is becoming the answer to many industry-wide obstacles. Here is how blockchain is applied to many of industry’s burgeoning issues:

Security

Healthcare systems are being targeted by cyber attacks because their legacy infrastructures make data vulnerable. In 2017, the ransomware “WannaCry” crippled the National Health Service (NHS) in the United Kingdom and affected over 150 countries. In 2018 and 2019 respectively, hackers broke into Singapore’s government health database and most recently the HIV status of over 14,000 people leaked online, Singapore authorities say.

Given that blockchain is a distributed ledger technology and does not require third-party interventions, it allows institutions to decentralize their databases. Hence, by using blockchain, health care systems can significantly reduce their risk of being subject to cyber threats. It would take too much time and energy for hackers to access all of the nodes within the network and to infect the system.

It is highly important to create an environment where clinicians, administrators, and patients (also known as consumers of healthcare) know that their privacy and data are protected. Such an ecosystem can be enabled by blockchain, either by allowing users to own their information by joining the chain or by helping hospitals to secure their servers and distribute the data on a network.

Physicians and administrators can significantly benefit from blockchain as the technology would allow them to share a common platform.Pixabay

Efficiency & Coordination

Health care systems are remarkably inefficient. Since they operate with many independent databases, especially in large centralized systems, there is a lack of cohesive communication between these distinct silos. By creating a unified ecosystem of data, distributed ledger software encourages cooperation between networks, improving payment processing, patient tracking, and enterprise workflow.

Sectors like the food industry are already seeing wins with blockchain that healthcare can emulate in regards to supply chain management.  Companies like Walmart implemented IBM’s blockchain for food traceability, impacting pharmaceutical stakeholders to participate in the non-profit Center For Supply Chain Studies DSCSA and Blockchain Phase 2 Study. The FDA who is behind this initiative, as declared by current FDA Commissioner Gottleib requires all entities governed under FDA  “full implementation of the Drug Supply Chain Security Act, [and] to make sure that every link in the U.S. Drug Supply must be secure.”

Other emerging use cases such as clinical trials involve the management of numerous locations, sources, and stakeholders, along with supervision of substantial amounts of sensitive data. Since blockchain may facilitate data storage, the technology can fuel innovation, as researchers will have greater access to medical record information.

The Future of Healthcare

Blockchain technology is expected to transform the way key players in health care systems interact with each other. Nonetheless, this technological revolution can only succeed with consortium thinking, which implies collaboration between all stakeholders in the sector. In the United States, Synaptic Health Alliance, a diverse consortium of healthcare organizations and other emerging startup consortia are working to identify and monetize shared opportunities in the blockchain space.

Blockchain is not without its problems.

Right now the initial costs can be high, and the integrations need to happen. Currently, most blockchain networks are designed so transactions are publicly accessible. While blockchain systems can be made private and permissible, making it so only certain parties can access boils down to aligned incentives. But it’s clear that the technology is there and can change healthcare for good.

Source link http://bit.ly/2GvON7c

[mccartneynathxzw83]

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Why The Next Evolution Of Global Health Care Will Be Blockchain-Based

Blockchain technology can improve how researchers access medical data.Pixabay.

This distributed ledger technology can improve security, efficiency, and the coordination of health care systems as an answer to aging legacy infrastructures.

Health care systems are cornerstones of all modern societies since they provide vital services. As they grow, however, many become less efficient and secure, which can make health care services more expensive and less accessible to the general public. Beyond being the buzzword of 2017, blockchain opens the door to solutions in an increasing global healthcare expenditure that is expected to increase to USD $10.059 trillion by 2022.

Healthcare Today

While the digitization of healthcare has paved the way for modern infrastructure, current privacy laws, software, and databases have slowly taken the power from the patient. Our existing software faces a few key problems that have both short-term and long-term implications—affecting both healthcare providers and their patients. Inefficiency, disjunction between databases, the disempowerment of patients, high expenses, and security concerns are just some of the many problems the healthcare industry faces.

With a move towards ease of access to data and decentralization in a world where security continues to pose a serious risk, blockchain is becoming the answer to many industry-wide obstacles. Here is how blockchain is applied to many of industry’s burgeoning issues:

Security

Healthcare systems are being targeted by cyber attacks because their legacy infrastructures make data vulnerable. In 2017, the ransomware “WannaCry” crippled the National Health Service (NHS) in the United Kingdom and affected over 150 countries. In 2018 and 2019 respectively, hackers broke into Singapore’s government health database and most recently the HIV status of over 14,000 people leaked online, Singapore authorities say.

Given that blockchain is a distributed ledger technology and does not require third-party interventions, it allows institutions to decentralize their databases. Hence, by using blockchain, health care systems can significantly reduce their risk of being subject to cyber threats. It would take too much time and energy for hackers to access all of the nodes within the network and to infect the system.

It is highly important to create an environment where clinicians, administrators, and patients (also known as consumers of healthcare) know that their privacy and data are protected. Such an ecosystem can be enabled by blockchain, either by allowing users to own their information by joining the chain or by helping hospitals to secure their servers and distribute the data on a network.

Physicians and administrators can significantly benefit from blockchain as the technology would allow them to share a common platform.Pixabay

Efficiency & Coordination

Health care systems are remarkably inefficient. Since they operate with many independent databases, especially in large centralized systems, there is a lack of cohesive communication between these distinct silos. By creating a unified ecosystem of data, distributed ledger software encourages cooperation between networks, improving payment processing, patient tracking, and enterprise workflow.

Sectors like the food industry are already seeing wins with blockchain that healthcare can emulate in regards to supply chain management.  Companies like Walmart implemented IBM’s blockchain for food traceability, impacting pharmaceutical stakeholders to participate in the non-profit Center For Supply Chain Studies DSCSA and Blockchain Phase 2 Study. The FDA who is behind this initiative, as declared by current FDA Commissioner Gottleib requires all entities governed under FDA  “full implementation of the Drug Supply Chain Security Act, [and] to make sure that every link in the U.S. Drug Supply must be secure.”

Other emerging use cases such as clinical trials involve the management of numerous locations, sources, and stakeholders, along with supervision of substantial amounts of sensitive data. Since blockchain may facilitate data storage, the technology can fuel innovation, as researchers will have greater access to medical record information.

The Future of Healthcare

Blockchain technology is expected to transform the way key players in health care systems interact with each other. Nonetheless, this technological revolution can only succeed with consortium thinking, which implies collaboration between all stakeholders in the sector. In the United States, Synaptic Health Alliance, a diverse consortium of healthcare organizations and other emerging startup consortia are working to identify and monetize shared opportunities in the blockchain space.

Blockchain is not without its problems.

Right now the initial costs can be high, and the integrations need to happen. Currently, most blockchain networks are designed so transactions are publicly accessible. While blockchain systems can be made private and permissible, making it so only certain parties can access boils down to aligned incentives. But it’s clear that the technology is there and can change healthcare for good.

Source link http://bit.ly/2GvON7c

[interwork2018-blog]

THE MOST INNOVATIVE THINGS ARE HAPPENING WITH BLOCKCHAIN FOR DSCSA DRUG SERIALIZATION

The Dynamic Duo: Blockchain for DSCSA Drug Serialization

The US Congress has enacted the drug supply chain security act 2013. Since then, technology businesses have aggressively explored all possible permutations and combinations of technology. The objective has been to build solutions to build a highly reliable system that closely works to help companies seamlessly scale without worrying about DSCSA serialization compliance.

The motive behind Blockchain for DSCSA Drug Serialization is to counter increasing time-material costs of supply chain operations, restricted supplies due to the productivity of employees, and excessively increase turnaround time in fulfilling requirements at the bulk level in the pharmaceutical supply chain. Ultimately, a sustainable Solution of Blockchain for DSCSA Drug Serialization has turned out to be the most beneficial one. Let us see how.

Innovations with Blockchain for DSCSA Drugs Serialization

While there are some changes to the Blockchain for Drug Serialization for DSCSA, the most primitive ones are:

A Single Solution, Double Purpose

One of the significant problems is that it is not able to seamlessly integrate with existing technology resources. Blockchain is capable of offering an all-round supply chain management solution instead of just focusing on Blockchain for DSCSA Serialization requirements. If the adoption of Blockchain for DSCSA Drug Serialization is Strategic, it offers the completeness of solutions for long-term stellar growth.

Multi-stakeholder operations

Other solutions just offer convincing answers to one, two, or a maximum of three stakeholders who are the primary supply chain partners. But according to US FDA, DSCSA serialization requires a top-notch level of communication in a highly secured environment for efficiently curbing drug counterfeiting. The dire need for enhancing drug track and trace capability is promoting Blockchain for DSCSA Drug Serialization.

Best use of Decentralized Database

A Blockchain for DSCSA Serialization offers a decentralized database accessible to all supply chain partners enhancing Blockchain-Based Drug Track and Trace. It also comes with an added innovation which lets regulatory bodies and US FDA regulators to conveniently fetch the transacting drug lot database from any timeline during the passage of the lots between any two supply chain partners.

Counterfeit Detection System

The newest innovations in the blockchain for DSCSA drug serialization make blockchain-based drug track and trace solutions highly capable of implementing improve counterfeit detection systems. Any discrepancies or a non-uniformity is in redirected transactions from different stakeholders down the line of all Pharma supply chain critically flagged for scrutiny by supply chain partners and regulatory bodies.

Real-Time Transaction and Notification System

Blockchain-Based Drug Track and Trace has greatly innovated to make life easier for major Pharma supply chain partners in the US market. They are doing so by helping suppliers and partners receive notifications of all transactions anywhere in the supply chain, which they can acknowledge after verification with all serialization relevant data. These notifications capable of driving positive attention of all regulatory bodies and supply chain partners to leave no scope for uncontrolled introduction of counterfeit into the mainstream supply chain.

Seamless Database Migration & Adoption

Innovative use of Blockchain for DSCSA Drug Serialization opens up the unlimited scope of migration and adoption of a new database as per DSCSA serialization standards. According to the DSCSA, all suppliers and partners are expected to maintain a highly active database, including all details like:

What to Expect From the Future?

Supply chain components like third party verification

The localization of a database copy

Integration scenarios like ERP-SCM

Data interoperability

AI-IoT based systems for warehousing, counterfeit, SCM operations

Conclusion

As the essential deadline for DSCSA full completion of serialization infrastructure set up nears, Blockchain-Based Drug Track and Trace will become an inevitable part of US-based pharmaceutical supply chain management business. Businesses that will pay required attention to proper efforts with Blockchain for DSCSA Drug Serialization with the right blockchain-based drug track and track solution will reach excellent benefits with an unbeatable advantage over others. In the future, USFDA takes strict measures and issue sanctions for tightening screws on drug counterfeiting in the upcoming years.

[interwork2018-blog]

THE NEED OF THE HOUR- DRUG SUPPLY CHAIN SECURITY ACT SOFTWARE

Drug Supply Chain Security Act Software

options in 2019

According to statistics, about 60% of US-based firms in supply chain partners have successfully initiated giant strides to go to the adoption of a drug supply chain security and software. As a majority of the pharmaceutical market shifts towards blockchain-based DSCSA software, entities failing to adopt or showing reluctance in adoption of an effective drug supply chain security and the software will face unintentional exclusion. It will also have direct repercussions on business relations, ease of scaling of the pharma supply chain market, and compliance tasks. Yes, it is the need of the hour to start using Drugs Supply Chain Security Act Software by 2020.

Ten Indisputable reasons to buy a

DSCSA Software

No Serialization means no business(Compliance Compulsion)

DSCSA is the second title under DQSA, as acted by US Congress in November 2013. It is important to note that US-based pharma supply chain partners failing to comply with DSCSA will not be permitted to carry out operations in the mainstream. It is also going to cause a significant slowdown in business followed by DSCSA non-compliance penalties, which may extend up to indefinite suspension of operations.

Non-Compliance Causes Penalties (DQSA, DSCSA Serialization)

DSCSA Serialization Compliance has huge liabilities, which the US FDA expects every supply chain partner to fulfill. These include lot-to-package level serialization and acknowledgment of drug lot transactions as and when required alongside accessible data fetching capabilities for regulatory audits and regulatory bodies. Dynamic supply chain businesses looking to scale into markets find it difficult, and DSCSA Software is a must to avoid any penalties.

Single Solution for all Stakeholders

(No hassle, Complete Transparency)

All US-based firms in supply chain partners are advised to adopt a Drug Supply Chain Security Act Software. It can bring all supply chain partners in an ecosystem, including the manufacturers, repackagers, wholesalers, dispensers, third-party logistics partners, and retailers onto a single system for highly transparent compliance solutions. The shared environment is a must for broadcasting communication and counterfeit detection, and consensus a management system is beneficial in such a scenario.

Decentralized to the core(Same Database, Multiple Copies)

A highly decentralized database which records all supply chain transactions in the form of immutable records or smart contracts is a must. Leading DSCSA software is everything the centralized database for highly transparent supply chain management channels supporting real-time transactions.

Anomaly Detection(100% Counterfeit Tracking)

All leading Drug Supply Chain Security Act Software is enabled with a foolproof and only detection system that offers a hundred percent coverage with counterfeit tracking. Any discrepancies in data or detected anomalies are raised as flag notifications to all supply chain partners and regulatory authorities for convenient checking and immediate tracking and traceability in case of any counterfeit, stolen drugs.

Higher Profitability (No Counterfeits)

It is a great advantage of using a robust DSCSA Software that a reduced number of counterfeit drug lots exponential increases the profitability. Every year a loss of up to $3 billion is reported due to counterfeit drugs that are illegally introduced into the branded supply chain, causing a loss of reputation and profit to pharmaceutical companies.

A lot to package level Serialization (2D bar code carrying its National Drug Code, a unique serial number to that NDC, the lot number, and expiration date )

DSCSA Serialization Compliance requires all medicine packages up to the lowest saleable level to carry an aggregated information label, including all the relevant and prescribed information including GTIN, lot number, expiry date, global drug code. A DSCSA Software helps you manage the inflow and outflow of a highly scalable database as drug lots pass through the supply chain with complete security and ease.

80% Business Accounting Vanishes(Highly Adaptive and DSCSA-Oriented Database Model)

Turn on the best benefits of avoiding by the DSCSA Drug Serialization Compliances that replicate a lot of the internal business tasks that are required for accounting and general business processes for any pharmaceutical supply chain partner. It is a great idea to opt for highly secured, robust DSCSA software that has functionalities which abide by the requirements of information passage across supply chain partners in real-time transactions.

Sustainable Data-Driven Culture(Scope for Analytics, Other Technologies)

Using a DSCSA Software automatically increases the ability to systematically documenting supply chain transactions and all the information on the accounts of drugs that passed through the supply chain. It also includes the logistic and sales and manufacturing business figures, which are documented correctly over A long period. You can conveniently use this data in different views for building a data-driven culture and an increasing scope of analytics that makes a supply chain business be more profitable with an extensive possibility of new-age technology adoption in the future. Using a Drug Supply Chain Security Act Software is bound to keep you on toes with all the technological updates.

Higher productivity (Highly Automated, Regulated Supply Chain Transitions)

When all the information is governed by a single source of truth that keeps on passing from one supply chain to another on a decent realize database, a DSCSA Software is bound to shoot a supply chain business productivity. Automated accounting and anomaly detection for the count to feature store and drugs increases the product of productivity profit exponentially.

Bottomline

DSCSA Serialization can plan shouldn’t be taken as a burden but yardstick to help your business pedal through technologically advanced business processes and compliance with global standards. A leading Drug Supply Chain Security Act Software is of great use solving all problems with blockchain for DSCSA Drug Serialization Solution.

[mccartneynathxzw83]

SAP targets counterfeit drugs with blockchain tracker

SAP targets counterfeit drugs with blockchain tracker

SAP has launched a supply chain tracking service based on blockchain that will enable drug wholesalers to authenticate pharmaceutical packaging returned from hospitals and pharmacies.

The Information Collaboration Hub for Life Sciences will initially be used to trace the return of unused drugs to wholesalers, but SAP this week said it plans to expand use of the distributed ledger technology to include a broader range of pharmaceutical supply chain processes.

There are about 60 million pharmaceutical returns made to U.S. wholesalers annually, worth an estimated $7 billion.

While the financial services and shipping industries have been quick to deploy blockchain, the healthcare industry is expected to follow their lead as it looks to increase efficiency and security, reduce costs and expand services using blockchain.

MF3d / Getty Images

In essence, blockchain could help reshape healthcare interoperability by serving as a next-generation middleware that couples healthcare data with decentralized, distributed, and immutable qualities, according to a report released last year by IDC Health Insights.

As a result, by 2020, 20% of healthcare organizations will have moved beyond pilot projects and be “using blockchain for operations management and patient identity,” the report said.

Blockchain’s interoperability could underpin data exchange, serving as an alternative to today’s health information exchanges (HIEs); essentially, it would act as a mesh network for transmitting secure, near real-time patient data for healthcare providers, pharmacies, insurance payers and clinical researchers, according to IDC.

Last fall, SAP announced it was working with more than two dozen produce, pharmaceutical, tech and shipping companies on an automated blockchain-based supply chain tracking system designed to bolster visibility and ensure the authenticity of goods such as food and drugs.

The software giant has piloted its SAP Cloud Platform Blockchain with 16 farm-to-consumer produce suppliers such as Maple Leaf Foods, Johnsonville, Naturipe Farms, Tate & Lyle and Natura. SAP’s blockchain-as-a-service (BaaS) provides an abstraction layer that supports open standards and offers built-in integration with SAP applications.

In terms of the pharma community, SAP hopes its blockchain-based tracker can be used to enable compliance with Unique Identification of Medicinal Products (IDMP) standards, which include messaging specifications designed to enable unambiguous drug identification anywhere in the world.

In the meantime, SAP said, the immutable blockchain tracking system will enable compliance with the U.S. Drug Supply Chain Security Act (DSCSA), which takes effect in November and requires wholesalers to verify prescription drugs that are returned and intended for resale.

The new software allows customers to verify the product code, lot, expiration date and a unique serial number embedded in the barcode against manufacturers’ data stored in the blockchain. The software was developed in coordination with drug wholesalers AmerisourceBergen, Boehringer Ingelheim AG & Co. KG, GlaxoSmithKline plc and Merck Sharp & Dohme, among others.

“Connection to SAP Cloud Platform enables us to integrate third parties much more quickly into serialization processes in an agile supply chain and to vastly improve drug traceability,” Mary Mercado, head of Global IT Operations Services at Boehringer Ingelheim, said in a statement.

Along with being tracked via barcode scan, the data can be manually sent or received with each of a user’s defined trading partners, which would eliminate the need for a serialization system capable of using a B2B adapter or capable of cloud integration; instead, operators download and upload all data themselves.

“The blockchain-based solution from SAP provides the best opportunity to fully satisfy our need to be interoperable with our trading partners and their solutions,” Jeffery Denton, senior director of Global Secure Supply Chain for AmerisourceBergen Corp., said in a statement. “We have utilized this tool in a number of pilots supporting our efforts to be compliant with the latest U.S. FDA regulations. It supports our need for a single point of entry or exit while sharing business transaction information with trading partners in a secure environment.”

Source link http://bit.ly/2T1kIQn

[vanessawestwcrtr5]

SAP targets counterfeit drugs with blockchain tracker

SAP targets counterfeit drugs with blockchain tracker

SAP has launched a supply chain tracking service based on blockchain that will enable drug wholesalers to authenticate pharmaceutical packaging returned from hospitals and pharmacies.

The Information Collaboration Hub for Life Sciences will initially be used to trace the return of unused drugs to wholesalers, but SAP this week said it plans to expand use of the distributed ledger technology to include a broader range of pharmaceutical supply chain processes.

There are about 60 million pharmaceutical returns made to U.S. wholesalers annually, worth an estimated $7 billion.

While the financial services and shipping industries have been quick to deploy blockchain, the healthcare industry is expected to follow their lead as it looks to increase efficiency and security, reduce costs and expand services using blockchain.

MF3d / Getty Images

In essence, blockchain could help reshape healthcare interoperability by serving as a next-generation middleware that couples healthcare data with decentralized, distributed, and immutable qualities, according to a report released last year by IDC Health Insights.

As a result, by 2020, 20% of healthcare organizations will have moved beyond pilot projects and be “using blockchain for operations management and patient identity,” the report said.

Blockchain’s interoperability could underpin data exchange, serving as an alternative to today’s health information exchanges (HIEs); essentially, it would act as a mesh network for transmitting secure, near real-time patient data for healthcare providers, pharmacies, insurance payers and clinical researchers, according to IDC.

Last fall, SAP announced it was working with more than two dozen produce, pharmaceutical, tech and shipping companies on an automated blockchain-based supply chain tracking system designed to bolster visibility and ensure the authenticity of goods such as food and drugs.

The software giant has piloted its SAP Cloud Platform Blockchain with 16 farm-to-consumer produce suppliers such as Maple Leaf Foods, Johnsonville, Naturipe Farms, Tate & Lyle and Natura. SAP’s blockchain-as-a-service (BaaS) provides an abstraction layer that supports open standards and offers built-in integration with SAP applications.

In terms of the pharma community, SAP hopes its blockchain-based tracker can be used to enable compliance with Unique Identification of Medicinal Products (IDMP) standards, which include messaging specifications designed to enable unambiguous drug identification anywhere in the world.

In the meantime, SAP said, the immutable blockchain tracking system will enable compliance with the U.S. Drug Supply Chain Security Act (DSCSA), which takes effect in November and requires wholesalers to verify prescription drugs that are returned and intended for resale.

The new software allows customers to verify the product code, lot, expiration date and a unique serial number embedded in the barcode against manufacturers’ data stored in the blockchain. The software was developed in coordination with drug wholesalers AmerisourceBergen, Boehringer Ingelheim AG & Co. KG, GlaxoSmithKline plc and Merck Sharp & Dohme, among others.

“Connection to SAP Cloud Platform enables us to integrate third parties much more quickly into serialization processes in an agile supply chain and to vastly improve drug traceability,” Mary Mercado, head of Global IT Operations Services at Boehringer Ingelheim, said in a statement.

Along with being tracked via barcode scan, the data can be manually sent or received with each of a user’s defined trading partners, which would eliminate the need for a serialization system capable of using a B2B adapter or capable of cloud integration; instead, operators download and upload all data themselves.

“The blockchain-based solution from SAP provides the best opportunity to fully satisfy our need to be interoperable with our trading partners and their solutions,” Jeffery Denton, senior director of Global Secure Supply Chain for AmerisourceBergen Corp., said in a statement. “We have utilized this tool in a number of pilots supporting our efforts to be compliant with the latest U.S. FDA regulations. It supports our need for a single point of entry or exit while sharing business transaction information with trading partners in a secure environment.”

Source link http://bit.ly/2T1kIQn

[bobbynolanios88]

SAP targets counterfeit drugs with blockchain tracker

SAP targets counterfeit drugs with blockchain tracker

SAP has launched a supply chain tracking service based on blockchain that will enable drug wholesalers to authenticate pharmaceutical packaging returned from hospitals and pharmacies.

The Information Collaboration Hub for Life Sciences will initially be used to trace the return of unused drugs to wholesalers, but SAP this week said it plans to expand use of the distributed ledger technology to include a broader range of pharmaceutical supply chain processes.

There are about 60 million pharmaceutical returns made to U.S. wholesalers annually, worth an estimated $7 billion.

While the financial services and shipping industries have been quick to deploy blockchain, the healthcare industry is expected to follow their lead as it looks to increase efficiency and security, reduce costs and expand services using blockchain.

MF3d / Getty Images

In essence, blockchain could help reshape healthcare interoperability by serving as a next-generation middleware that couples healthcare data with decentralized, distributed, and immutable qualities, according to a report released last year by IDC Health Insights.

As a result, by 2020, 20% of healthcare organizations will have moved beyond pilot projects and be “using blockchain for operations management and patient identity,” the report said.

Blockchain’s interoperability could underpin data exchange, serving as an alternative to today’s health information exchanges (HIEs); essentially, it would act as a mesh network for transmitting secure, near real-time patient data for healthcare providers, pharmacies, insurance payers and clinical researchers, according to IDC.

Last fall, SAP announced it was working with more than two dozen produce, pharmaceutical, tech and shipping companies on an automated blockchain-based supply chain tracking system designed to bolster visibility and ensure the authenticity of goods such as food and drugs.

The software giant has piloted its SAP Cloud Platform Blockchain with 16 farm-to-consumer produce suppliers such as Maple Leaf Foods, Johnsonville, Naturipe Farms, Tate & Lyle and Natura. SAP’s blockchain-as-a-service (BaaS) provides an abstraction layer that supports open standards and offers built-in integration with SAP applications.

In terms of the pharma community, SAP hopes its blockchain-based tracker can be used to enable compliance with Unique Identification of Medicinal Products (IDMP) standards, which include messaging specifications designed to enable unambiguous drug identification anywhere in the world.

In the meantime, SAP said, the immutable blockchain tracking system will enable compliance with the U.S. Drug Supply Chain Security Act (DSCSA), which takes effect in November and requires wholesalers to verify prescription drugs that are returned and intended for resale.

The new software allows customers to verify the product code, lot, expiration date and a unique serial number embedded in the barcode against manufacturers’ data stored in the blockchain. The software was developed in coordination with drug wholesalers AmerisourceBergen, Boehringer Ingelheim AG & Co. KG, GlaxoSmithKline plc and Merck Sharp & Dohme, among others.

“Connection to SAP Cloud Platform enables us to integrate third parties much more quickly into serialization processes in an agile supply chain and to vastly improve drug traceability,” Mary Mercado, head of Global IT Operations Services at Boehringer Ingelheim, said in a statement.

Along with being tracked via barcode scan, the data can be manually sent or received with each of a user’s defined trading partners, which would eliminate the need for a serialization system capable of using a B2B adapter or capable of cloud integration; instead, operators download and upload all data themselves.

“The blockchain-based solution from SAP provides the best opportunity to fully satisfy our need to be interoperable with our trading partners and their solutions,” Jeffery Denton, senior director of Global Secure Supply Chain for AmerisourceBergen Corp., said in a statement. “We have utilized this tool in a number of pilots supporting our efforts to be compliant with the latest U.S. FDA regulations. It supports our need for a single point of entry or exit while sharing business transaction information with trading partners in a secure environment.”

Source link http://bit.ly/2T1kIQn

[courtneyvbrooks87]

SAP targets counterfeit drugs with blockchain tracker

SAP targets counterfeit drugs with blockchain tracker

SAP has launched a supply chain tracking service based on blockchain that will enable drug wholesalers to authenticate pharmaceutical packaging returned from hospitals and pharmacies.

The Information Collaboration Hub for Life Sciences will initially be used to trace the return of unused drugs to wholesalers, but SAP this week said it plans to expand use of the distributed ledger technology to include a broader range of pharmaceutical supply chain processes.

There are about 60 million pharmaceutical returns made to U.S. wholesalers annually, worth an estimated $7 billion.

While the financial services and shipping industries have been quick to deploy blockchain, the healthcare industry is expected to follow their lead as it looks to increase efficiency and security, reduce costs and expand services using blockchain.

MF3d / Getty Images

In essence, blockchain could help reshape healthcare interoperability by serving as a next-generation middleware that couples healthcare data with decentralized, distributed, and immutable qualities, according to a report released last year by IDC Health Insights.

As a result, by 2020, 20% of healthcare organizations will have moved beyond pilot projects and be “using blockchain for operations management and patient identity,” the report said.

Blockchain’s interoperability could underpin data exchange, serving as an alternative to today’s health information exchanges (HIEs); essentially, it would act as a mesh network for transmitting secure, near real-time patient data for healthcare providers, pharmacies, insurance payers and clinical researchers, according to IDC.

Last fall, SAP announced it was working with more than two dozen produce, pharmaceutical, tech and shipping companies on an automated blockchain-based supply chain tracking system designed to bolster visibility and ensure the authenticity of goods such as food and drugs.

The software giant has piloted its SAP Cloud Platform Blockchain with 16 farm-to-consumer produce suppliers such as Maple Leaf Foods, Johnsonville, Naturipe Farms, Tate & Lyle and Natura. SAP’s blockchain-as-a-service (BaaS) provides an abstraction layer that supports open standards and offers built-in integration with SAP applications.

In terms of the pharma community, SAP hopes its blockchain-based tracker can be used to enable compliance with Unique Identification of Medicinal Products (IDMP) standards, which include messaging specifications designed to enable unambiguous drug identification anywhere in the world.

In the meantime, SAP said, the immutable blockchain tracking system will enable compliance with the U.S. Drug Supply Chain Security Act (DSCSA), which takes effect in November and requires wholesalers to verify prescription drugs that are returned and intended for resale.

The new software allows customers to verify the product code, lot, expiration date and a unique serial number embedded in the barcode against manufacturers’ data stored in the blockchain. The software was developed in coordination with drug wholesalers AmerisourceBergen, Boehringer Ingelheim AG & Co. KG, GlaxoSmithKline plc and Merck Sharp & Dohme, among others.

“Connection to SAP Cloud Platform enables us to integrate third parties much more quickly into serialization processes in an agile supply chain and to vastly improve drug traceability,” Mary Mercado, head of Global IT Operations Services at Boehringer Ingelheim, said in a statement.

Along with being tracked via barcode scan, the data can be manually sent or received with each of a user’s defined trading partners, which would eliminate the need for a serialization system capable of using a B2B adapter or capable of cloud integration; instead, operators download and upload all data themselves.

“The blockchain-based solution from SAP provides the best opportunity to fully satisfy our need to be interoperable with our trading partners and their solutions,” Jeffery Denton, senior director of Global Secure Supply Chain for AmerisourceBergen Corp., said in a statement. “We have utilized this tool in a number of pilots supporting our efforts to be compliant with the latest U.S. FDA regulations. It supports our need for a single point of entry or exit while sharing business transaction information with trading partners in a secure environment.”

Source link http://bit.ly/2T1kIQn